Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
05/2003
05/15/2003US20030092727 Hydroxamic and carboxylic acid derivatives
05/15/2003US20030092721 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092700 Benzazepine derivatives, medicaments containing the same and their use to prepare medicaments
05/15/2003US20030092694 Central nervous system disorders; side effect reduction
05/15/2003CA2465744A1 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/14/2003EP1310254A1 Medicinal compositions containing camptothecin derivative and ph regulating agent
05/14/2003EP1309597A2 Polymorphs of an epothilone analog
05/14/2003EP1309589A2 Urea compounds and methods of uses
05/14/2003EP1309551A1 Indoline derivatives as 5ht2c antagonists
05/14/2003EP1226145B1 Naphthopyrans with a heterocycle in the 5,6-position, preparation, and compositions and matrices containing them
05/14/2003EP1048651B1 Nitrogen-containing tetracyclic compounds
05/14/2003EP0932609B1 AZAHETEROCYCLYMETHYL DERIVATIVES OF 2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO 2,3-e]INDOL-8-ONE
05/14/2003EP0877738B1 Process for the preparation of phenylimidazolidine derivatives
05/14/2003CN1418204A Method for production of spirocyclic tetronic acid derivatives
05/13/2003US6562968 Preparing sample by dissolving tetrodotoxin in a weak organic acid; applying tetrodotoxin solution to a chromatography column comprising an octyldecylsilane stationary phase and chromatographically separating sample using mobile phase
05/13/2003US6562810 8-substituted-9H-1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives, as AMPA/kainate receptor inhibitors
05/13/2003CA2021467C Heterocyclically substituted sulfonylureas, process for their preparation, and their use as herbicides or plant growth regulators
05/08/2003WO2003037904A1 Novel 3beta-amino azabicyclooctane heteroaromatic amide derivatives, preparation method and therapeutic uses thereof
05/08/2003WO2003037271A2 Compounds, pharmaceutical compositions and methods of use therefor
05/08/2003WO2002048152A3 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
05/08/2003US20030088110 Novel chiral derivatives of hibiscus acid bearing lactone ring moiety, process for preparing the same and a convenient method for the large-scale isolation of hibiscus acid
05/08/2003US20030088102 Novel process for producing fused imidazopyridine derivatives and novel crystal form
05/08/2003US20030088101 E-ring expanded camptothecin derivatives
05/08/2003US20030087926 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives
05/08/2003US20030087925 Benzoamide piperidine containing compounds and related compounds
05/08/2003US20030087916 Pyrimidin-4-one compounds
05/08/2003US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol
05/08/2003US20030087902 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents
05/08/2003US20030087895 Fused imidazole derivatives as multidrug resistance modulators
05/08/2003US20030087888 Anticancer agents
05/08/2003US20030087882 Antiinflammatory agents
05/07/2003EP1307460A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof
05/07/2003EP1307459A2 Indole compounds useful for the treatment of cancer
05/07/2003EP1307453A2 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers
05/07/2003EP1307204A1 Protease inhibitors
05/07/2003EP1307203A1 Protease inhibitors
05/07/2003EP1307196A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
05/07/2003EP0841929B1 Quinolones and their therapeutic use
05/07/2003EP0719272B1 Pyrimidine derivatives for labeled binding partners
05/07/2003EP0614898B1 Indole derivative, process for producing the same, and medicinal use thereof
05/07/2003CN1416346A Peotease inhibitors
05/07/2003CN1107678C Highly lipophilic camptothcin derivatives, its prepn. method and uses
05/07/2003CN1107677C Camptothecin derivatives and use thereof as antimutor agents
05/07/2003CN1107502C Prepn. method for medicinal compsn. contg. hydrogonated pyridine derivative as active components
05/06/2003US6559312 Intermediates useful for the preparation of antihistaminic piperidine derivatives
05/06/2003US6559309 Preparation for camptothecin and camptothecin-like compounds and to novel intermediates used in this preparation. The process for the preparation of the camptothecin derivative known by 7-(4
05/02/2003EP1306373A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/02/2003EP1305308A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1021448B1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS
05/02/2003EP0672047B1 ANTIALLERGIC IMIDAZO[1,2-a]THIENO[ 2,3-d]AZEPINE DERIVATIVES
05/02/2003EP0662078B1 Reagents for peptide couplings
05/01/2003WO2003035650A1 Entry inhibitor
05/01/2003WO2003035644A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003WO2003035643A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
05/01/2003WO2003035076A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
05/01/2003WO2003035065A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
05/01/2003WO2003034987A2 Androgen receptor modulators and methods of use thereof
05/01/2003WO2002094840A3 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
05/01/2003WO2002079186A3 Aminopiperidine derivatives as modulators of chemokine receptor activity
05/01/2003US20030083499 Pyridomorphinans and use thereof
05/01/2003US20030083495 Coupling, acylation, treating with an allyl bromide, reduction, desilylation, cyclization and reduction
05/01/2003US20030083333 1,4-Disubstituted benzo-fused compounds
05/01/2003US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/01/2003US20030083327 Inhibitors of Aurora-2 protein kinases and Glycogen synthase kinase-3 (GSK-3); cancer, diabetes, Alzheimer's disease, and schizophrenia treatment
05/01/2003US20030083268 Isoquinoline compounds having antiinfective activity
05/01/2003US20030080323 Novel methine compound, material for organic luminescence element, and organic luminescence element using the same
05/01/2003CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003CA2463975A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
05/01/2003CA2463311A1 Androgen receptor modulators and methods of use thereof
04/2003
04/30/2003CN1107069C Derivatives of camptothecin for use in treating cancer and its use
04/29/2003US6555689 Intermediates useful for the preparation of antihistaminic piperidine derivatives
04/29/2003US6555567 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides
04/29/2003US6555542 Sulfonamide lactam inhibitors of FXa and method
04/24/2003WO2003033501A1 Himbacine analogues as thrombin receptor antagonists
04/24/2003WO2003032911A2 Anti-angiogenic and cytotoxic fused pyrimidines
04/24/2003WO2003032897A2 Azabicyclic compounds for the treatment of fibromyalgia syndrome
04/24/2003WO2002088134A3 Antipsychotic aminomethyl derivatives of 1,3,7,8-tetrahydro-6,9-dioxa-1,3-diaza-cyclopenta[a]-naphthalen-2-one
04/24/2003WO2002085848A3 Synthesis of pancratistatin prodrugs
04/24/2003WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003WO2002056875A3 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance
04/24/2003US20030078279 For therapy and prophylaxis of pain, central nervous system disorder or the like in mammalian subjects
04/24/2003US20030078278 Spiropiperidine compounds as ligands for ORL-1 receptor
04/24/2003US20030078277 For therapy and prophylaxis of depression; Tourette syndrome, autism, bipolar disorder, cyclothymia, schizophrenia, Alzheimer disease, obesity, diabetes, alcohol dependence, sleep disorder, insomnia, migraine, stress headache, etc.
04/24/2003US20030078275 For therapy of cancer, diabetes and Alzheimer's disease
04/24/2003US20030078268 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene
04/24/2003US20030078249 VLA-4 inhibitor compounds
04/24/2003US20030078166 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003CA2722197A1 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same
04/24/2003CA2463628A1 Himbacine analogues as thrombin receptor antagonists
04/23/2003EP1303641A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
04/23/2003EP1303519A1 Tricyclic imidazopyridines
04/23/2003EP1303497A1 Substituted amidoalkyl-uracils as parp inhibitors
04/23/2003EP1035848B1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels
04/23/2003EP0915846B1 2- and 2,5-substituted phenylketoenols
04/23/2003EP0873315B1 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives
04/23/2003EP0844998B1 Halobenzimidazoles and their use as microbicides
04/23/2003CN1413205A 2-(1H-indol-3-yl)-2-oxo-acetamides with antitumor activity
04/22/2003US6552200 Intermediates useful for the preparation of antihistaminic piperidine derivatives
04/22/2003US6552197 Condensed-hexacyclic compounds and a process therefor